Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Masanori Kamei is active.

Publication


Featured researches published by Masanori Kamei.


Bioscience, Biotechnology, and Biochemistry | 2013

Oxidative Stress during Development of Alcoholic Fatty Liver: Therapeutic Potential of Cacao Polyphenol

Koichiro Suzuki; Kiyotaka Nakagawa; Taiki Miyazawa; Shunji Kato; Fumiko Kimura; Masanori Kamei; Teruo Miyazawa

The lipid and antioxidative/oxidative profiles of livers from rats fed an ethanol liquid diet for 8 weeks provided evidence for an involvement of oxidative stress (e.g., phospholipid peroxidation) in the development of alcoholic fatty liver (AFL), possibly in an early stage. Cacao polyphenol supplementation produced an ameliorating effect, and may help in AFL prevention.


Human antibodies and hybridomas | 1995

Immunocytochemical detection of lung cancer cells with monoclonal antibodies to 14-3-3 proteins.

Yuko Setoguchi; Masatoshi Kato; Masahiro Shoji; Tsutomu Honjoh; Masanori Kamei; Masanori Sugitani; Susumu Sato; Shuichi Hashizume; Takeshi Hanagiri; Takashi Yoshimatsu; Kozo Nakanishi; Kosei Yasumoto; Akira Nagashima; Hisashi Nakahashi; Tatsuo Suzuki; Tadaaki Imai; Sanetaka Shirahata; Kikuo Nomoto

Murine monoclonal antibodies were raised against 14-3-3 proteins, the antigen of human monoclonal antibody AE6F4 which had been shown potentially useful for the immunochemical diagnosis of lung cancer via sputum cytology. Enzyme-linked immunosorbent assays of the murine anti-14-3-3 monoclonal antibodies with isolated bovine brain 14-3-3 isoforms showed that the antibodies were classified into four different profiles of isoform reactivity. The comparison of 14-3-3 isoform and lung cancer tissue on the reactivity with murine monoclonal antibodies indicated that beta isoform can be responsible for cancer recognition, whereas human monoclonal antibody AE6F4 showed preferential binding to zeta isoform. No murine monoclonal antibody of the same isoform specificity as human monoclonal antibody AE6F4 was obtained. Since murine monoclonal antibodies with different isoform specificities could immunostain lung cancer cells in sputum successfully, the combination use of murine monoclonal anti-14-3-3 antibodies with human monoclonal antibody AE6F4 is potentially useful for facilitating the sputum cytodiagnosis of lung cancer.


Human antibodies | 1993

Cancer-specific binding of a mouse MAb vs. Candida krusei cytochrome c: an antigen recognized by a cancer-associated human MAb HB4C5.

Kosei Yasumoto; Yuko Setoguchi; Masanori Kamei; Masatoshi Kato; Kikuo Nomoto; Hiroki Murakami; Shuichi Hashizume

More than 60 mouse monoclonal antibodies directed to cytochrome c from Candida krusei with different specificities were raised. Most of these monoclonal antibodies, except for three of them, did not cross-react with bovine cytochrome c. By the immunoblotting method, the monoclonal antibodies of clones HCC 5-13, 9-2, and 10-5 reacted with the Candida cytochrome c, which had been transferred onto nitrocellulose membrane, but those of clones HCC 1-22, 6-3, and 17-3 did not, although all these monoclonal antibodies strongly reacted with coated Candida cytochrome c on plastic immunoplates when examined by ELISA. On the contrary, monoclonal antibody activities of clones HCC 1-22, 6-3, and 17-3 in binding to the coated cytochrome c in ELISA were inhibited competitively by the addition of extra Candida cytochrome c, whereas those of clones HCC 5-13, 9-2, and 10-5 were not inhibited. Among these monoclonal antibodies, the antibody of clone HCC 6-3, which showed a good reactivity to added cytochrome c in inhibiting ELISA reaction but was not reactive with the transblotted cytochrome c on nitrocellulose, was found to be reactive with human lung cancer tissues specifically with no reactivity to normal tissues. The immunostaining of lung cancer tissue showed that this mouse monoclonal antibody to Candida cytochrome c reacted to the cytoplasmic fraction of the cancer cells specifically.


Human antibodies | 1991

Serodiagnosis of cancer by using Candida cytochrome c recognized by human monoclonal antibody HB4C5

Shuichi Hashizume; Masanori Kamei; Katsumi Mochizuki; Susumu Sato; Kazuhiko Kuroda; Masatoshi Kato; Kosei Yasumoto; H. Nakahashi; H. Hirose; H. Tai; H. Okano; Kikuo Nomoto; Hiroki Murakami

Cytochrome c from various sources, such as Candida krusei, yeast, horse, and cattle, was found to be recognized by human monoclonal antibody HB4C5 specific to lung cancer. Therefore, the cytochrome c was applied to the measurement of antibody amount in patient sera with a similar reactivity to the antibody HB4C5 for serodiagnosis of cancer. The cytochrome c from Candida krusei was most valuable for the serodiagnosis of various cancers, and the yeast cytochrome c was also useful. However, horse and bovine cytochrome c did not react with antibody of the cancer patients. By using Candida cytochrome c lung, bile duct, esophagus, and liver cancers were detected at high rates of more than 50%. In the case of lung cancer, the detection rates of small-cell, squamous, large-cell and adenocarcinoma were 78%, 63%, 100%, and 34%, respectively. The rate for small-cell carcinoma was higher than that with the currently used NSE assay system, and the rate for squamous carcinoma was comparable to that with the SCC assay system, although the system using cytochrome c did not show similar reactivity to that with the SCC system. Furthermore, lung cancer was detected at early stages by using cytochrome c, and even in the case of adenocarcinoma, the rate at early stages with the cytochrome c system was higher than that with the CEA assay system. On the other hand, false positive rates of benign diseases and normal were low--8% and 2%, respectively.


Human antibodies | 1991

Serodiagnosis of cancer using porcine carboxypeptidase A as an animal antigen recognized by human monoclonal antibody HB4C5

Shuichi Hashizume; Katsumi Mochizuki; Masanori Kamei; Kazuhiko Kuroda; Masatoshi Kato; Susumu Sato; Kosei Yasumoto; H. Nakahashi; K. Tsuchimoto; M. Muraoka; Kikuo Nomoto; Hiroki Murakami

Protein from hog which is recognized by human monoclonal antibody (HB4C5), generated from a patient with large cell lung carcinoma, was identified as carboxypeptidase A by comparison of the protein with carboxypeptidase A in enzymatic activity, immunologic reactivity, and amino acid sequence. Carboxypeptidase A activity was also found in human cancer tissue, and purified antigen from cancer tissue recognized by the antibody HB4C5 was reacted with rabbit anti-carboxypeptidase A serum, indicating that carboxypeptidase A is an antigen of HB4C5. Since large amounts of carboxypeptidase A can be obtained from porcine sources, a simple method for its purification was established. The fraction which was most reactive with HB4C5 was obtained from acetone powder of porcine pancreas by successive applications of water extraction, ammonium sulfate precipitation, trypsin treatment, and Mono Q column chromatography. Its apparent molecular weight was 40,000, according to SDS polyacrylamide gel electrophoresis. When the reactivity of IgG in sera with the purified carboxypeptidase A was measured, the detection rates for lung, ovary, larynx, uterus, and liver cancer were more than 50%, while the rates for stomach and breast cancer were around 30%, and pancreatic cancer, benign diseases, and normal controls were minimally detected.


Bioscience, Biotechnology, and Biochemistry | 2014

Theobromine enhances absorption of cacao polyphenol in rats

Takayuki Yamamoto; Haruya Takahashi; Koichiro Suzuki; Akira Hirano; Masanori Kamei; Tsuyoshi Goto; Nobuyuki Takahashi; Teruo Kawada

Several concentrations of theobromine (TB) and (−)-epicatechin (EC) were coadministered to rats, and plasma EC and its metabolites were determined using ultra-high-performance liquid chromatography–tandem mass spectrometry. It has been demonstrated that TB increases the absorption of EC in a dose-dependent manner. Cocoa powder had a similar effect, and the mechanism involved is not thought to depend on tight junctions.


Bioscience, Biotechnology, and Biochemistry | 1996

Production of Recombinant Human Monoclonal Antibody Using ras-Amplified BHK-21 Cells in a Protein-free Medium

Yuichi Inoue; Lourdes Bouzo Lopez; Seiji Kawamoto; Nobuhisa Arita; Kiichiro Teruya; Kiyohiko Seki; Masahiro Shoji; Masanori Kamei; Shuichi Hashizume; Yasumitsu Shiozawa; Hirofumi Tachibana; Hideya Ohashi; Kosei Yasumoto; Akira Nagashima; Hisashi Nakahashi; Tatsuo Suzuki; Tadaaki Imai; Kikuo Nomoto; Mitsuhiro Takenoyama; Yoshinori Katakura; Sanetaka Shirahata


Human antibodies and hybridomas | 1994

Specific reactivity of human monoclonal antibody AE6F4 against cancer cells in tissues and sputa from lung cancer patients.

Masahiro Shoji; Seiji Kawamoto; Susumu Sato; Masanori Kamei; Masatoshi Kato; Shuichi Hashizume; Kiyohiko Seki; Kosei Yasumoto; Akira Nagashima; Hisashi Nakahashi


Archive | 2005

Composition for lowering internal lipid content

Yumiko Tani; Tatsuo Watanabe; Masanori Kamei; Masatoshi Kato; Koji Yanae


Archive | 2004

Composition permettant de reduire le taux de lipides corporels

Yumiko Tani; Tatsuo Watanabe; Masanori Kamei; Masatoshi Kato; Koji Yanae

Collaboration


Dive into the Masanori Kamei's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yumiko Tani

Nagoya Women's University

View shared research outputs
Researchain Logo
Decentralizing Knowledge